Image Image Image Image Image Image Image Image Image Image
Accessibilité
Haut de page

Up

· 17/02/2016

Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study.

· 21/10/2015

Scheduled versus Pro Re Nata Dosing in the VIEW Trials.

Harrier

· 28/09/2015

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration

DMAE (RTH258)

· 21/09/2015

HARRIER (RHT258)

_MG_8240

· 12/06/2015

TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations.

· 15/05/2015

Increased Fundus Autofluorescence and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GAIN Study.

AG_assaigCHROMA

· 29/01/2015

CHROMA: Clinical Trial of Lampalizumab for Geographic Atrophy Secondary to Age-Related Macular Degeneration

Injeccions

· 19/12/2014

FOVISTA NR: Clinical Trial for neovascular age-related macular degeneration

Lite 1

· 21/12/2014

LITE: Development of Advanced Laser Imaging Techniques for the anterior and posterior Eye

Foto2

· 01/01/2015

FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration

DMAE atrofica

· 19/03/2014

Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD

Foto4_def

· 31/03/2014

Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD

Foto44_3

· 20/12/2014

MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration  

Foto49_3

· 20/12/2014

Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD

color nvc

· 16/01/2015

A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.

Last modified: 21 July, 2019 - 21:34